RNA Avidity Biosciences, Inc.

Avidity Biosciences, Inc. engages in the research and development of biopharmaceutical products. It develops Nano-Medicine Platform that provides nano-medicines for the treatment of cancer and other diseases. The company was founded by Troy E. Wilson, Kent Hawryluk, Mark E. Davis and Francis Patrick McCormick on November 13, 2012 and is headquartered in La Jolla, CA.

$13.39  +0.64 (5.02%)
As of 05/26/2022 15:59:55 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  06/12/2020
Outstanding shares:  49,763,363
Average volume:  301,916
Market cap:   $634,482,878
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BMWHPY1
Valuation   (See tab for details)
PE ratio:   -4.94
PB ratio:   1.67
PS ratio:   74.67
Return on equity:   -34.18%
Net income %:   -1,525.48%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy